Form 8-K - Current report:
SEC Accession No. 0001193125-13-020114
Filing Date
2013-01-23
Accepted
2013-01-23 09:00:31
Documents
4
Period of Report
2013-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d474520d8k.htm 8-K 22333
2 FORM OF WARRANTS TO PURCHASE SHARES OF COMMON STOCK d474520dex41.htm EX-4.1 91742
3 FORM OF SUBSCRIPTION AGREEMENT d474520dex101.htm EX-10.1 152538
4 FORM OF REGISTRATION RIGHTS AGREEMENT d474520dex102.htm EX-10.2 132480
  Complete submission text file 0001193125-13-020114.txt   400466
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 13541632
SIC: 2835 In Vitro & In Vivo Diagnostic Substances